Andrés Fabricio Caballero-Lozada

Andrés Fabricio Caballero-Lozada

Auto-generated profile, based on publicly available information

Andrés Fabricio Caballero-Lozada

Department of Anaesthesiology, Universidad del Valle, Cali, Colombia

Research Focus & Metrics

Academic Career Length

58Years (1969-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2019 in Regional Anesthesia & Pain Medicine
Verified
Journal Article
Closed access
AZAndrés Zorrilla-Vaca
Andrés Zorrilla-Vaca
ASAlexander Stone
Alexander Stone
ACAndres Fabricio Caballero-Lozada
Andres Fabricio Caballero-Lozada
SPStephania Paredes
Stephania Paredes
MGMichael Conrad Grant
Michael Conrad Grant
Background: Multimodal analgesia is a fundamental part of modern surgery and enhanced recovery pathways. Duloxetine, a serotonin and norepinephrine reuptake inhibitor, has been validated for the treatment of chronic neuropathic pain. The evidence for duloxetine as an adjunct for the treatment of acute postoperative pain remains controversial. We conducted a meta-analysis to determine the efficacy of duloxetine in the acute perioperative setting.Methods: A literature search was conducted in the major databases (PubMed, EMBASE and Google Scholar) for randomized controlled trials (RCTs) evaluating duloxetine compared with placebo control for acute postoperative pain. The primary outcome was postoperative pain assessed at 2, 4, 6, 24 and 48 hours time frames. Secondary outcomes included postoperative opioid administration, as well as side effects, such as postoperative nausea/vomiting (PONV), pruritus, dizziness and headache.Results: 574 patients (n=9 RCTs) were included in the analysis, divided between duloxetine (n=285 patients) and placebo (n=289 patients). Duloxetine use was associated with a significant reduction in pain scores as early as 4 (mean difference (MD) −0.9, 95% CI −1.33 to −0.47) and as late as 48 (MD −0.94, 95% CI −1.56 to −0.33) hours postoperatively compared with placebo. In addition, duloxetine was associated with a significant reduction in opioid administration at 24 (standardized MD (SMD) −2.24, 95% CI −4.28 to −0.19) and 48 (SMD −2.21, 95% CI −4.13 to −0.28) hours as well as a significant reduction in PONV (risk ratio 0.69, 95% CI 0.49 to 0.95, p=0.03) compared with placebo. There was no difference between groups in other side effects.Conclusion: Duloxetine, a non-opioid neuromodulator, may provide efficacy for the treatment of acute perioperative pain. Additional prospective studies are required to establish optimal perioperative dosing regimens, role in the setting of a comprehensive multimodal analgesic plan and impact on chronic postsurgical pain.PROSPERO registration number: CRD42019121416

16 September 2024 in Frontiers in Sports and Active Living
Verified
Journal Article
Open access
PDF file
NCNathali Carvajal-Tello
Nathali Carvajal-Tello
JOJosé Guillermo Ortega
José Guillermo Ortega
ACAndrés Fabricio Caballero-Lozada
Andrés Fabricio Caballero-Lozada
MDMaría Juliana Devia-Quiñonez
María Juliana Devia-Quiñonez
IGIsabella González-Calzada
Isabella González-Calzada
ANAndr
Andr
Background: This systematic review and meta-analysis aimed to assess the impact of inspiratory muscle training (IMT) on lung function parameters (MIP, MEP, FEV1, and FVC) between both elite and non-elite swimmers.Methods: We searched for controlled clinical trials (CCT) and prospective longitudinal studies (PLS) in elite and non-elite swimmers following an inspiratory muscle training (IMT) protocol with a standardized device, published between 2012 and 2023. The databases used in the search were PubMed, Science Direct, Scopus, Springer, Cochrane Central Register of Controlled Trials, and Google Scholar. The primary outcome assessed was the impact of IMT on lung function parameters, including MIP, MEP, FEV1, and FVC.Results: We selected 13 articles involving 277 subjects aged 11–21 years, with 61.4% being male, and 84.6% being elite swimmers. The most commonly used IMT device was the PowerBreathe®, prescribed for 3–12 weeks, 1–2 sessions per day, 3–6 times per week, with 30 repetitions, starting at 50% of MIP and progressing up to 80%. The meta-analysis showed that IMT was associated with a higher MIP (MD = 29.35 cmH2O, 95% CI: 13.04–45.65 cmH2O, p < 0.01) without affecting FEV1 and FVC.Conclusion: The swimmers that used IMT improved muscle strength, specifically MIP, without changes in MEP, FEV1, and FVC.

10 March 2020 in Journal of Intensive Care Medicine
Verified
Journal Article
Closed access
PDF file
ACAndrés Fabricio Caballero-Lozada
Andrés Fabricio Caballero-Lozada
KNKapil Laxman Nanwani Nanwani
Kapil Laxman Nanwani Nanwani
FPFavio Pavón
Favio Pavón
AZAndrés Zorrilla-Vaca
Andrés Zorrilla-Vaca
CZCarolina Zorrilla-Vaca
Carolina Zorrilla-Vaca
Ultrasonography is part of the multimodal monitoring of the neurocritical patient. Through transcranial color Doppler ultrasound, carotid-color Doppler ultrasound, and ocular ultrasound it is possible to diagnose and monitor a multitude of pathological conditions, such as cerebrovascular events, vasospasm, Terson syndrome, carotid atheromatosis, and brain death. Furthermore, these techniques enable the monitoring of the intracranial pressure, the cerebral perfusion pressure, and the midline deviation, which allows us to understand the patient’s neurocritical pathology at their bedside, in a noninvasive way. Although none of these tools have yet been shown to improve patient prognosis, the dissemination of knowledge and management of neurovascular ultrasonography could significantly improve the comprehensive management of neurocritical patients.

31 December 1969 in Colombian Journal of Anesthesiology
Verified
Journal Article
Open access
PDF file
ACAndrés Fabricio Caballero-Lozada
Andrés Fabricio Caballero-Lozada
JGJuan Manuel Gómez
Juan Manuel Gómez
JRJorge A Ramírez
Jorge A Ramírez
MPMónica Posso
Mónica Posso
AZAndrés Zorrilla-Vaca
Andrés Zorrilla-Vaca
LLLuis Fernando Lasso
Luis Fernando Lasso
Introduction: Pain control in total knee arthroplasty (TKA) is a determining factor in the patient's rehabilitation process. With conventional peripheral blocking techniques for the posterior compartment, foot drop, and distal motor deficit have been reported. The infiltration between popliteal artery and capsule of the knee (IPACK) block is a promising emerging analgesic technique. Objective: To describe analgesic control, opioid consumption, and mobility of patients scheduled for TKA using IPACK block as adjunct analgesic to the femoral block. Methods: We conducted a prospective observational cohort study over a 6-month period in adults taken to TKA. Sociodemographic and anthropometric characteristics, laterality, postoperative pain, and opioid consumption, patient and surgeon satisfaction (Likert), postoperative nausea and vomiting, and walk in the first 24hours, were evaluated and reported with a descriptive analysis. Results: Twenty-seven patients taken to TKA received an IPACK block. The pain score remained in a mild level during the 48 hours of evaluation. In 73% of the cases, an opioid rescue dose was not required; 81% of the patients managed to walk in the first 24 hours. Conclusion: The IPACK block, combined with femoral block and neuraxial anesthesia, turn out to be an excellent analgesic strategy for TKA, achieving adequate pain management, prompt rehabilitation, and early ambulation of the patient.

1 April 2018 in Colombian Journal of Anesthesiology
Verified
Journal Article
Open access
ACAndrés Fabricio Caballero
Andrés Fabricio Caballero
KVKaren Villarreal
Karen Villarreal
Background: Ultrasound (US)-guided central venous catheterization is intended to reduce complications, enhance success rates on the first attempt, and increase accuracy, thus becoming a standard in clinical practice. Objective: To review the relevant literature on the importance of US as a guide to central venous access and to describe the benefits of this tool and the impact of its use on the safety of the procedure. Methods: A narrative review of various medical literature databases and recognized guidelines (National Guideline Clearinghouse, New Zealand Guidelines, National Institute for Clinical Excellence, Cochrane, and JAMA). Results: High-quality evidence recommends US-guided internal jugular vein access as the preferred approach in routine practice. However, different other anatomical sites may be necessary for vascular access depending on the clinical setting. Related complications associated with landmark-guided techniques range between 0.3% and 18.8% and depend on multiple conditions such as patient characteristics and access site. US has been associated with a reduction in the relative risk of complications, failed attempts, and failed first attempt of 57%, 86%, and 41%, respectively. Conclusion: US should be used routinely in central vascular access. Current evidence supports this recommendation for the internal jugular vein approach, but no so for the other approaches, in cases of difficult or failed access using conventional approaches. Resumen Introducción: El catéter guiado por ultrasonido busca impactar en la incidencia de complicaciones, aumentar las tasas de éxito en el primer intento, e incrementar la precisión; convirtiéndose en estándar en la práctica clínica. Objetivo: Elaborar una revisión de la literatura más relevante sobre la importancia del ultrasonido (US) como guía para la canulación de accesos vasculares centrales y hacer una descripción sobre los beneficios de esta herramienta y cómo impacta en la seguridad del procedimiento Métodos: Revisión narrativa; se consultaron diferentes bases de datos, como National Guideline Clearinghouse, New Zeland Guidelines, Medline, NICE, Cochrane, JAMA. Resultados: El abordaje para un catéter venoso central que tiene suficiente evidencia para recomendar su uso rutinario guiado por US, es en vena yugular interna, pero no quiere decir que ésta deba prevalecer sobre situaciones en las cuales esté indicado un catéter venoso central por otra vía. Las complicaciones de las técnicas guiadas por referencias anatómicas oscilan entre 0,3% a 18,8%, por múltiples variables como la población de pacientes, sitio de inserción; se han impactado con el uso del US en reducción del riesgo relativo de complicaciones, intentos fallidos y fracaso primer intento en 57%, 86% y 41%, respectivamente. Conclusión: El ultrasonido debe ser rutinario para obtener un acceso vascular central, la evidencia actual soporta esta recomendación en vena yugular interna, no tanto así para los demás abordajes; en aquellos casos de canalización difícil o fallida por métodos convencionales, en cualquiera de las vías descritas hay que utilizar el ecógrafo como herramienta para garantizar el éxito.

31 August 2022 in Journal of Anaesthesiology Clinical Pharmacology
Verified
Journal Article
Open access
ACAndrés Fabricio Caballero-Lozada
Andrés Fabricio Caballero-Lozada
JGJuan Manuel Gómez
Juan Manuel Gómez
ATArley Torres-Mosquera
Arley Torres-Mosquera
ÁGÁlvaro González-Carvajal
Álvaro González-Carvajal
AMAndrea Marín-Prado
Andrea Marín-Prado
JLJinlei Li
Jinlei Li
Post-operative nausea and vomiting (PONV) is an event of multifactorial origin with an incidence of 30% in the general population. Opioids such as fentanyl are being used as adjuvant to local anesthetic for its antiemetic effect. In this context, with this study we aimed to evaluate the impact of spinal fentanyl as an adjuvant on the incidence of PONV compared with a placebo, and shivering. A systematic search of randomized controlled trials that evaluated the use of spinal fentanyl in the prevention of PONV and shivering was conducted in different databases, of which 32 studies met the inclusion criteria. A total of 2116 patients scheduled for various surgeries, including cesarean section, orthopedic surgery in the lower limb, hysterectomy, and transurethral resection of the prostate, were included in the final analysis. The meta-analysis estimated the relative risk of incidence of PONV in the first 24 hours after surgery and secondary outcomes included the shivering symptom. The use of intrathecal fentanyl was associated with lower incidence of PONV, but not statistically significant when compared to the placebo (RR: 0.74 CI95%: 0.55-1.01 P = 0.06). Subgroup analysis showed a statistically significant reduction in PONV incidences with lower doses between 10 and 15 μg (RR: 0.44 CI95%: 0.35–0.55 P < 0.00001, I2 = 0%) but not with higher doses 20–25 μg. Secondary outcomes showed a decrease in incidence with the use of fentanyl vs the placebo (RR: 0.49, CI95% 0.33-0.72 P = 0.0003). Current evidence shows that the use of spinal fentanyl decreases the incidence of PONV, an effect favored using low doses.